Impact of siderophore production on Pseudomonas aeruginosa infections in immunosuppressed mice.
Pseudomonas aeruginosa produces siderophores, pyoverdin and pyochelin, for high-affinity iron uptake. To investigate their contribution to P. aeruginosa infections, we constructed allelic exchange mutants from strain PAO1 which were deficient in producing one or both of the siderophores. When inoculated into the calf muscles of immunosuppressed mice, pyochelin-deficient and pyoverdin-deficient mutants grew and killed the animals as efficiently as PAO1. In contrast, the pyochelin- and pyoverdin-deficient (double) mutant did not show lethal virulence, although it did infect the muscles. On the other hand, when inoculated intranasally, all mutants grew in the lungs and killed immunosuppressed mice. Compared with PAO1, however, the pyoverdin-deficient mutant and the double mutant grew poorly in the lungs, and the latter was significantly attenuated for virulence. Irrespective of the inoculation route, the pyoverdin-deficient and doubly deficient mutants detected in the blood were significantly less numerous than PAO1. Additionally, in vitro examination demonstrated that the growth of the double mutant was extremely reduced under a free-iron-restricted condition with apotransferrin but that the growth reduction was completely canceled by supplementation with hemoglobin as a heme source. These results suggest that both pyoverdin and pyochelin are required for efficient bacterial growth and full expression of virulence in P. aeruginosa infection, although pyoverdin may be comparatively more important for bacterial growth and dissemination. However, the siderophores were not always required for infection. It is possible that non-siderophore-mediated iron acquisition, such as via heme uptake, might also play an important role in P. aeruginosa infections.
Takase
H
H
New Product Research Laboratories I, Daiichi Pharmaceutical Co., Ltd., Tokyo 134-8630, Japan. takas4px@daiichipharm.co.jp
Nitanai
H
H
Hoshino
K
K
Otani
T
T
D018528:ATP-Binding Cassette Transporters / Q000096:biosynthesis; D000281:Administration, Intranasal; D000483:Alleles; D000818:Animals; D001059:Apoproteins / Q000494:pharmacology; D001426:Bacterial Proteins; D004305:Dose-Response Relationship, Drug; D005290:Ferric Compounds / Q000494:pharmacology; D006454:Hemoglobins / Q000494:pharmacology; D007165:Immunosuppression Therapy; D007273:Injections, Intramuscular; D008297:Male; D051379:Mice; D006899:Mixed Function Oxygenases / Q000096:biosynthesis; D016254:Mutagenesis, Insertional; D010453:Peptide Synthases / Q000096:biosynthesis; D016133:Polymerase Chain Reaction; D011552:Pseudomonas Infections / Q000276:immunology / Q000382:microbiology*; D011550:Pseudomonas aeruginosa / Q000235:genetics / Q000378:metabolism*; D011994:Recombinant Proteins / Q000378:metabolism; D017262:Siderophores / Q000096:biosynthesis*; D013997:Time Factors; D014168:Transferrin / Q000494:pharmacology; D014774:Virulence
D018528:ATP-Binding Cassette Transporters; D001059:Apoproteins; D001426:Bacterial Proteins; D005290:Ferric Compounds; D006454:Hemoglobins; C102466:PvdE protein, Pseudomonas aeruginosa; D011994:Recombinant Proteins; D017262:Siderophores; D014168:Transferrin; C028284:apotransferrin; C024823:ferric sulfate; D006899:Mixed Function Oxygenases; C059419:ornithine N5-oxygenase; D010453:Peptide Synthases; C091136:pyoverdine synthetase protein, Pseudomonas